Akanda corp. announces registered direct offering priced at-the-market under nasdaq rules

London, united kingdom--(newsfile corp. - february 2, 2024) - akanda corp. (nasdaq: akan) ("akanda" or the "company"), an international medical cannabis company, today announced that it has entered into a securities purchase agreement with certain accredited investors whereby the investors have agreed to purchase 280,851 common shares at a purchase price of $0.406 per share and pre-funded warrants to purchase 1,462,991 common shares in a registered direct offering priced at-the-market under nasdaq rules. the purchase price of each pre-funded warrant is equal to the price at which one common share is sold in the offering, minus $0.0001, and the exercise price of each pre-funded warrant is $0.0001 per share.
AKAN Ratings Summary
AKAN Quant Ranking